Top 10 Companies in the (4H)-1,2,4-Triazol-3-amine (CAS 65312-61-0) Market (2026): Market Leaders Powering Global Demand

MARKET INSIGHTS

Global (4H)-1,2,4-Triazol-3-amine (CAS 65312-61-0) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.7 million by 2034, exhibiting a CAGR of 6.4% during the forecast period.

(4H)-1,2,4-Triazol-3-amine, also known as 3‑amino‑1,2,4‑triazole or amitrole, is a heterocyclic organic compound characterized by its triazole ring structure with an amine functional group. With a molecular formula of C…H…N and a molecular weight of 84.08 g/mol, this compound serves as a versatile building block in pharmaceutical synthesis, agrochemical formulations, and specialty chemical manufacturing. It is widely recognized for its role as an intermediate in the production of herbicides, antifungal agents, and corrosion inhibitors.

The market is witnessing steady growth driven by expanding demand from the pharmaceutical and agrochemical industries, where (4H)-1,2,4-Triazol-3-amine functions as a key synthetic intermediate. Furthermore, rising investments in specialty chemicals research and the growing need for effective crop protection solutions globally are reinforcing market momentum. Key producers and fine chemical suppliers operating across North America, Europe, and Asia‑Pacific continue to expand their production capabilities to meet rising global demand.

(4H)-1,2,4-Triazol-3-amine (CAS 65312-61-0) Market – View in Detailed Research Report

🔟 10. Capot Chemical Co., Ltd.

Headquarters: China
Key Offering: High‑purity (≥98%) (4H)-1,2,4‑Triazol‑3‑amine for pharmaceutical and agrochemical intermediates

Capot Chemical has established a robust production line capable of delivering consistent quality at scale. Its focus on process optimization and quality control ensures that each batch meets stringent pharmacopeial standards, making it a preferred partner for large‑volume pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Investment in green chemistry protocols to reduce solvent usage by 30%
• Expansion of production capacity in Shenzhen to meet rising demand from Asia‑Pacific pharma hubs
• Partnerships with academic institutions to develop next‑generation triazole derivatives

🟨 9. Hairui Fine Chemical Co., Ltd.

Headquarters: China
Key Offering: Custom‑grade (4H)-1,2,4‑Triazol‑3‑amine for agrochemical and fine‑chemical applications

Hairui Fine Chemical excels at tailoring synthesis routes to meet specific purity and functional group requirements. Its agile production model allows rapid scale‑up for emerging agrochemical markets.

Sustainability & Growth Initiatives:

• Adoption of renewable feedstocks for triazole synthesis
• Certification under REACH and GMP for expanded global reach
• Collaboration with regional agro‑chemical firms to co‑develop new fungicide candidates

🟧 8. Finetech Industry Limited

Headquarters: China
Key Offering: High‑purity (4H)-1,2,4‑Triazol‑3‑amine for pharmaceutical intermediates and specialty chemicals

Finetech’s state‑of‑the‑art synthesis platform incorporates continuous flow chemistry, enabling consistent product quality and reduced waste.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recycling systems
• Strategic expansion into Southeast Asian markets through joint ventures
• Investment in analytical instrumentation for real‑time purity monitoring

🟦 7. Enamine LLC

Headquarters: Ukraine
Key Offering: Custom synthesis and rapid‑delivery services for triazole intermediates used in drug discovery

Enamine’s expertise in combinatorial chemistry makes it a go‑to partner for pharma companies seeking diverse triazole libraries.

Sustainability & Growth Initiatives:

• Green synthesis pathways that minimize hazardous by‑products
• Digital platform for order tracking and inventory management
• Collaboration with academic research centers to explore novel triazole applications

🟪 6. Biosynth Carbosynth

Headquarters: Switzerland
Key Offering: High‑purity (4H)-1,2,4‑Triazol‑3‑amine for pharmaceutical and agrochemical intermediates

Biosynth Carbosynth combines Swiss precision with scalable production, delivering products that meet the highest regulatory standards.

Sustainability & Growth Initiatives:

• Investment in bio‑based solvent systems
• Partnerships with European pharma firms to co‑develop advanced antifungals
• Implementation of ISO 9001 and ISO 14001 certifications across all sites

🟧 5. Taizhou Crene Biotechnology Co., Ltd.

Headquarters: China
Key Offering: High‑purity (4H)-1,2,4‑Triazol‑3‑amine for agrochemical intermediates and specialty chemicals

Taizhou Crene focuses on cost‑effective synthesis routes that maintain product quality while reducing production costs.

Sustainability & Growth Initiatives:

• Development of catalytic processes that cut solvent usage by 25%
• Expansion of plant capacity to support emerging biotech startups in China
• Collaboration with local universities for talent development in heterocyclic chemistry

🟦 4. TargetMol

Headquarters: China
Key Offering: Custom‑grade (4H)-1,2,4‑Triazol‑3‑amine for pharmaceutical research and development

TargetMol’s rapid synthesis platform enables quick turnaround for research laboratories seeking high‑purity intermediates.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient synthesis modules
• Strategic partnerships with global pharma R&D centers
• Continuous improvement of purification processes to meet cGMP requirements

🟩 3. Ryan Scientific Inc.

Headquarters: USA
Key Offering: High‑purity (4H)-1,2,4‑Triazol‑3‑amine for pharmaceutical and agrochemical intermediates

Ryan Scientific combines American manufacturing expertise with a focus on quality, serving both domestic and international customers.

Sustainability & Growth Initiatives:

• Adoption of green chemistry protocols to lower carbon footprint
• Investment in digital supply‑chain visibility tools
• Collaboration with U.S. universities on triazole‑based drug discovery

🟨 2. ChemBridge Corporation

Headquarters: USA
Key Offering: High‑purity (4H)-1,2,4‑Triazol‑3‑amine for pharmaceutical intermediates and specialty chemicals

ChemBridge’s strong global distribution network ensures timely delivery to key pharmaceutical markets.

Sustainability & Growth Initiatives:

• Implementation of renewable energy in production facilities
• Development of low‑toxicity purification processes
• Strategic alliances with European pharma firms for joint R&D

🟦 1. MedKoo Biosciences Inc.

Headquarters: USA
Key Offering: High‑purity (4H)-1,2,4‑Triazol‑3‑amine for pharmaceutical and agrochemical intermediates

MedKoo Biosciences focuses on delivering high‑quality intermediates that support advanced drug development and crop protection solutions.

Sustainability & Growth Initiatives:

• Investment in carbon‑neutral manufacturing processes
• Partnerships with global pharma companies to co‑develop next‑generation antifungals
• Continuous improvement of waste‑management practices to exceed regulatory standards

Download FREE Sample Report: (4H)-1,2,4-Triazol-3-amine (CAS 65312-61-0) Market – View in Detailed Research Report

Get Full Report: (4H)-1,2,4-Triazol-3-amine (CAS 65312-61-0) Market – View in Detailed Research Report

Outlook

The (4H)-1,2,4‑Triazol‑3‑amine market is set to expand steadily as demand from pharmaceutical and agrochemical sectors continues to rise. The forecast indicates a steady increase in production volumes and revenues, driven by the compound’s indispensable role in synthesizing triazole‑based antifungal agents and advanced agrochemical formulations.

Future Trends

• Integration of green chemistry processes to reduce environmental impact and lower production costs.
• Growth of biotech applications, particularly in antiviral and anticancer drug development.
• Expansion into emerging markets such as Latin America and Africa, where crop protection needs are escalating.
• Digitalization of supply chains to enhance traceability and reduce lead times.